The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue

Journal of Pathology

Volumn 183, Issue 4, 1997, Pages 412-417

  Happerfield, Lisa C ^a   Miles, David W ^a   Barnes, Diana M ^a   Thomsen, Lindy L ^b   Smith, Paul ^a   Hanby, Andrew M ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Carcinoma; Endothelium; IGF; IGFR 1; Normal epithelium; Oestrogen receptor; Progesterone receptor

Indexed keywords

ESTROGEN RECEPTOR; INSULIN RECEPTOR; MONOCLONAL ANTIBODY; PROGESTERONE RECEPTOR; SOMATOMEDIN C RECEPTOR;

ANTIBODY PRODUCTION; ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER GRADING; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; MASTECTOMY; PRIORITY JOURNAL; RECEPTOR BINDING; TISSUE DISTRIBUTION; TUMOR GROWTH;

BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; EPITHELIUM; FEMALE; FIBROADENOMA; HUMANS; NEOPLASM PROTEINS; RECEPTOR, IGF TYPE 1; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0030670432     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199712)183:4<412::AID-PATH944>3.0.CO;2-4     Document Type: Article

References (32)

1. Zapf J, Froesch ER. Pathophysiological and clinical aspects of the insulin-like growth factors. Horm Res 1986; 24: 160-165.
2. Daughaday WH. Editorial: the possible autocrine/paraerine and endocrine roles of human insulin-like growth factors of human tumours. Endocrinology 1990; 127: 1.
3. Corps AN, Brown KD, Rees LH, Carr J, Prosser CG. The insulin-like growth factor 1 content in human milk increases between early and full lactation. J Clin Endocrinol Metab 1988; 67: 25-29.
4. Cullen KJ, Allison A, Martire I, Ellis M, Singer C. Insulin-like growth factor expression in breast cancer epithelium and stroma. Breast Cancer Res Treat 1992; 22: 21-29.
5. Yee D, Palk S, Lebovic, et al. Analysis of insulin-like growth factor 1R gene in malignancy: evidence for a paracrine role in human breast cancer. Mol Endocrinol 1989; 3: 509-517.
6. Cullen KJ, Yee D, Sly WS. et al Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 1990; 50: 48-53.
7. Arteaga CL, Kitten LJ, Coronado EB, et al. Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J Clin Invest 1989; 84: 1418-1423.
8. Arteaga CL, Osborne CK. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor. Cancer Res 1989; 49: 6237-6241.
9. Railo M, Smitten K, Pekonen F. The prognostic value of insulin-like growth factor-I in breast cancer patients. Results of a follow up study on 126 patients. Eur J Cancer 1994; 30: 307-311.
10. Foekens JA, Portengen H, van Putten WLJ, et al. Prognostic value of receptors for insulin-like growth factor 1, somatostatin and epidermal growth factor in human breast cancer. Cancer Res 1989; 49: 7002-7009.
11. Peyrat JP, Bonneterre JC, Amrani S, et al. Presence and characterisation of insulin-like growth factors in benign breast disease. Eur J Cancer Clin Oncol 1988; 24: 1425-1431.
12. Peyrat JP, Bonneterre J. Type I IGF receptor in human breast diseases. Breast Cancer Res Treat 1992; 22: 59-67.
13. Bonneterre J, Peyrat JP, Beuscart R, Demaille A. Prognostic significance of insulin-like growth factor 1 receptors in human breast cancer. Cancer Res 1990; 50: 6931-6935.
14. Peyrat JP, Bonneterre J, Beuscart R, Djiane J, Demaille A. Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors. Cancer Res 1988; 48: 6429-6433.
15. Berns EMJJ, Klijn JGM, van Staveren IL, Portengen H, Foekens JA. Sporadic amplification of the insulin-like growth factor 1 receptor gene in human breast tumors. Cancer Res 1992; 52: 1036-1039.
16. Jammes H, Peyrat JP, Ban E, et al. Insulin-like growth factor 1 receptors in human breast tumour: localisation and quantification by histoautoradiographic analysis. Br J Cancer 1992; 66: 248-253.
17. Elston CW, Ellis O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403-410.
18. Kull FC, Jacobs S, Su YF, Svobuda ME, Van Wyk JJ, Cuatrecasas P. Monoclonal antibodies to receptor for insulin and somatomedin C. J Biol Chem 1983; 258: 6561-6566.
19. Happerfield LC, Echezarreta G, Gillett CG, et al. Assessment of oestrogen and progesterone receptor antibodies in formalin-fixed routinely processes paraffin-wax embedded tissue. J Cell Pathol 1996; 1: 170-178.
20. Barnes DM, Harris WH, Smith P, Millis RR, Rubens RD. Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients. Br J Cancer 1996; 74: 1445-1451.
21. Hodak-E, Gottlieb AB, Anzilotti M, Krueger JG. The insulin-like growth factor 1 receptor is expressed by epithelial cells with proliferative potential in human epidermis and skin appendages: correlation of increased expression with epidermal hyperplasia. J Invest Dermatol 1996; 106: 564-570.
22. Meyers MG, Sun XJ, White MF. The IRS-1 signalling system. Trends Biochem Sci 1994; 19: 289-293.
23. Playford RJ, Hanby AM, Gschmeissner S, Peiffer LP, Wright NA, McGarrity T. The EGF-receptor (EGF-R) is present on the basolateral, but not the apical, surface of enterocytes in the human gastrointestinal tract. Gut 1996; 39: 262-266.
24. Clemmons DR, Elgin RG, Han VLM, et al. Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin C/insulin-like growth factor 1. J Clin Invest 1986; 77: 1548-1566.
25. Pekonen F, Partanen S, Makinen T, Rutanen EM. Receptors for epidermal growth factor and insulin-like growth factor 1 and their relation to steroid receptors in human breast cancer. Cancer Res 1988; 48: 1343-1347.
26. Weigang B, Nap M, Bittl A, Jaeger W. Immunohistochemical localisation of insulin-like growth factor 1 receptors in benign and malignant tissues of the female genital tract. Tumour Biol 1994; 15: 236-246.
27. Tang XM, Rossi MJ, Masterson BJ, Chegini M. Insulin-like growth factor 1 (IGF-1), IGF-1 receptors, and IGF binding proteins 1-4 in human uterine tissue: tissue localisation and IGF-1 action in endometrial stromal and myometrial smooth muscle cells in vitro. Biol Reprod 1994; 50: 1113-1125.
28. Bohm M, Blasius S, Roessner R. Immunohistochemical localisation of PDGF B, PDGF beta receptors and IGF-1 receptors during atherogenesis. Zentralbl Pathol 1994; 140: 357-362.
29. Stewart AJ, Johnson MD, May FEB, Westley BR. Role of insulin-like growth factors and the type 1 insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem 1990; 265: 21172-21178.
30. Papa V, Hartmann KKP, Rosenthal SM. Progestins induce down regulation of insulin-like growth factor-1 (IGF-1) receptors in human breast cancer cells: potential autocrine role of IGF-11. Mol Endocrinol 1991; 5: 709-717.
31. Lee A, Weng CN, Jackson JG, Yee D. Activation of estrogen receptor mediated gene-transcription by IGF-1 in human breast cancer cells. J Endocrinol 1997; 152: 39-47.
32. Clarke RB, Howell A, Anderson E. Type 1 insulin-like growth factor receptor gene expression. Br J Cancer 1997; 75: 251-257.